Stock 4574 TAIKO PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Taiko Pharmaceutical Co.,Ltd.

Equities

4574

JP3442200006

Delayed Japan Exchange
Other stock markets
 07:00:00 17/05/2024 BST 		5-day change 1st Jan Change
382 JPY 0.00% Intraday chart for Taiko Pharmaceutical Co.,Ltd. +7.30% +26.07%
02-09 Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2024 CI
2023 Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2024
CI
Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2023
CI
Kingworld Medicines Subsidiary Buys Shares in Taiko Pharmaceutical
MT
Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2023
CI
Cuorips Inc. has completed an IPO in the amount of ¥3.432 billion.
CI
Taiko Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Kingworld Medicines to Invest 832 Million Yen in Taiko Pharmaceutical
MT
Taiko Pharmaceutical to Pay 607 Million Yen Penalty; Shares Down 3%
MT
Taiko Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 2023
CI
Taiko Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022
CI
Taiko Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Year ending December 31, 2022
CI
Taiko Pharmaceutical Co.,Ltd. Omits to Pay Year-End Dividend for the Year Ended December 31, 2021
CI
Taiko Pharmaceutical Co.,Ltd. acquired Torishi S.A. de C.V.
CI
Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Quarter End December 2021
CI
Taiko Pharmaceutical Co.,Ltd. Announces Earnings Results for the Second Quarter of 2021
CI
Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Quarter End December 2021
CI
Ex-dividend day for interim dividend
FA
Almado, Inc. has completed an IPO in the amount of ¥4.664 billion.
CI
Almado, Inc. has filed an IPO.
CI
Taiko Pharmaceutical Co.,Ltd. Announces Earnings Results for the First Quarter of 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4574 Stock
  4. News Taiko Pharmaceutical Co.,Ltd.
  5. Highlights